Marshall University Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2008
NCT00899353
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Edwards Comprehensive Cancer Center, Marshall University (Huntington) | Marshall University | Professor Marshall University School of Medicine